Literature DB >> 28991697

Zika virus disease-associated Guillain-Barré syndrome-Barranquilla, Colombia 2015-2016.

Jorge L Salinas1, Diana M Walteros2, Ashley Styczynski3, Flavio Garzón2, Hernán Quijada2, Elsa Bravo4, Pablo Chaparro2, Javier Madero2, Jorge Acosta-Reyes5, Jeremy Ledermann3, Zuleima Arteta4, Erin Borland3, Paul Burns3, Maritza Gonzalez2, Ann M Powers3, Marcela Mercado2, Alma Solano4, James J Sejvar3, Martha L Ospina2.   

Abstract

BACKGROUND: An outbreak of Guillain-Barré syndrome (GBS), a disorder characterized by acute, symmetric limb weakness with decreased or absent deep-tendon reflexes, was reported in Barranquilla, Colombia, after the introduction of Zika virus in 2015. We reviewed clinical data for GBS cases in Barranquilla and performed a case-control investigation to assess the association of suspect and probable Zika virus disease with GBS.
METHODS: We used the Brighton Collaboration Criteria to confirm reported GBS patients in Barranquilla during October 2015-April 2016. In April 2016, two neighborhood and age range-matched controls were selected for each confirmed GBS case-patient. We obtained demographics and antecedent symptoms in the 2-month period before GBS onset for case-patients and the same period for controls. Sera were collected for Zika virus antibody testing. Suspected Zika virus disease was defined as a history of rash and ≥2 other Zika-related symptoms (fever, arthralgia, myalgia, or conjunctivitis). Probable Zika virus disease was defined as suspected Zika virus disease with laboratory evidence of a recent Zika virus or flavivirus infection. Conditional logistic regression adjusted for sex and race/ethnicity was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS: We confirmed 47 GBS cases. Incidence increased with age (10-fold higher in those ≥60years versus those <20years). We interviewed 40 case-patients and 79 controls. There was no significant difference in laboratory evidence of recent Zika virus or flavivirus infection between case-patients and controls (OR: 2.2; 95% CI: 0.9-5.1). GBS was associated with having suspected (OR: 3.0, 95% CI: 1.1-8.6) or probable Zika virus disease (OR: 4.6, CI: 1.1-19.0).
CONCLUSIONS: Older individuals and those with suspected and probable Zika virus disease had higher odds of developing GBS. KEY POINTS: We confirmed a Guillain-Barré syndrome (GBS) outbreak in Barranquilla, Colombia, during October 2015-April 2016. A case-control investigation using neighborhood controls showed an association of suspected and probable Zika virus disease with GBS. Published by Elsevier B.V.

Entities:  

Keywords:  Case-control studies; Colombia; Guillain-Barré syndrome; Zika virus

Mesh:

Year:  2017        PMID: 28991697     DOI: 10.1016/j.jns.2017.09.001

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

1.  Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika Virus.

Authors:  Jean A Bernatchez; Zunhua Yang; Michael Coste; Jerry Li; Sungjun Beck; Yan Liu; Alex E Clark; Zhe Zhu; Lucas A Luna; Christal D Sohl; Byron W Purse; Rongshi Li; Jair L Siqueira-Neto
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 2.  Zika virus epidemiology: from Uganda to world pandemic, an update.

Authors:  C Talero-Gutiérrez; A Rivera-Molina; C Pérez-Pavajeau; I Ossa-Ospina; C Santos-García; M C Rojas-Anaya; A de-la-Torre
Journal:  Epidemiol Infect       Date:  2018-03-14       Impact factor: 4.434

3.  Transfusion-Transmitted Zika Virus Infection in Pregnant Mice Leads to Broad Tissue Tropism With Severe Placental Damage and Fetal Demise.

Authors:  Wanbo Tai; Denis Voronin; Jiawei Chen; Weili Bao; Debra A Kessler; Beth Shaz; Shibo Jiang; Karina Yazdanbakhsh; Lanying Du
Journal:  Front Microbiol       Date:  2019-01-23       Impact factor: 5.640

4.  Long-term outcomes of Guillain-Barré syndrome possibly associated with Zika virus infection.

Authors:  Diana M Walteros; Jesus Soares; Ashley R Styczynski; Joseph Y Abrams; Jose I Galindo-Buitrago; Jorge Acosta-Reyes; Elsa Bravo-Ribero; Zuleima E Arteta; Alma Solano-Sanchez; Franklyn E Prieto; Maritza Gonzalez-Duarte; Edgar Navarro-Lechuga; Jorge L Salinas; Ermias D Belay; Lawrence B Schonberger; Inger K Damon; Martha L Ospina; James J Sejvar
Journal:  PLoS One       Date:  2019-08-01       Impact factor: 3.240

5.  Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.

Authors:  Wanbo Tai; Jiawei Chen; Yusen Zhou; Fang Li; Lanying Du; Guangyu Zhao; Qibin Geng; Lei He; Yuehong Chen
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

6.  Incidence of Guillain-Barré Syndrome (GBS) in Latin America and the Caribbean before and during the 2015-2016 Zika virus epidemic: A systematic review and meta-analysis.

Authors:  Ariadna Capasso; Danielle C Ompad; Dorice L Vieira; Annelies Wilder-Smith; Yesim Tozan
Journal:  PLoS Negl Trop Dis       Date:  2019-08-26

7.  Identification of Novel Natural Products as Effective and Broad-Spectrum Anti-Zika Virus Inhibitors.

Authors:  Yaning Gao; Wanbo Tai; Ning Wang; Xiang Li; Shibo Jiang; Asim K Debnath; Lanying Du; Shizhong Chen
Journal:  Viruses       Date:  2019-11-02       Impact factor: 5.048

Review 8.  Prevalence of asymptomatic Zika virus infection: a systematic review.

Authors:  Michelle M Haby; Mariona Pinart; Vanessa Elias; Ludovic Reveiz
Journal:  Bull World Health Organ       Date:  2018-04-27       Impact factor: 9.408

9.  Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barré syndrome: A living systematic review.

Authors:  Michel Jacques Counotte; Kaspar Walter Meili; Katayoun Taghavi; Guilherme Calvet; James Sejvar; Nicola Low
Journal:  F1000Res       Date:  2019-08-14

10.  Guillain-Barré syndrome related to Zika virus infection: A systematic review and meta-analysis of the clinical and electrophysiological phenotype.

Authors:  Sonja E Leonhard; Cristiane C Bresani-Salvi; Joanna D Lyra Batista; Sergio Cunha; Bart C Jacobs; Maria Lucia Brito Ferreira; Maria de Fatima P Militão de Albuquerque
Journal:  PLoS Negl Trop Dis       Date:  2020-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.